No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
etoposide IV Sensitive: A1 - Approval
|
etoposide IV Sensitive: A1 - Approval
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
cisplatin Sensitive: A1 - Approval
|
cisplatin Sensitive: A1 - Approval
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
ifosfamide Sensitive: A1 - Approval
|
ifosfamide Sensitive: A1 - Approval
|
No biomarker
|
Testicular Seminoma
|
No biomarker
|
Testicular Seminoma
|
TI-CE Sensitive: A2 - Guideline
|
TI-CE Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Seminoma
|
No biomarker
|
Testicular Seminoma
|
EP Sensitive: A2 - Guideline
|
EP Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Seminoma
|
No biomarker
|
Testicular Seminoma
|
VeIP Sensitive: A2 - Guideline
|
VeIP Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Seminoma
|
No biomarker
|
Testicular Seminoma
|
BEP Sensitive: A2 - Guideline
|
BEP Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Seminoma
|
No biomarker
|
Testicular Seminoma
|
carboplatin Sensitive: A2 - Guideline
|
carboplatin Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Seminoma
|
No biomarker
|
Testicular Seminoma
|
VIP Sensitive: A2 - Guideline
|
VIP Sensitive: A2 - Guideline
|
TMB-H
|
Testicular Seminoma
|
TMB-H
|
Testicular Seminoma
|
TIP Sensitive: A2 - Guideline
|
TIP Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
paclitaxel + gemcitabine Sensitive: A2 - Guideline
|
paclitaxel + gemcitabine Sensitive: A2 - Guideline
|
MSI-H/dMMR
|
Testicular Cancer
|
MSI-H/dMMR
|
Testicular Cancer
|
cemiplimab Sensitive: A2 - Guideline
|
cemiplimab Sensitive: A2 - Guideline
|
TMB-H
|
Testicular Cancer
|
TMB-H
|
Testicular Cancer
|
pembrolizumab Sensitive: A2 - Guideline
|
pembrolizumab Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
etoposide oral Sensitive: A2 - Guideline
|
etoposide oral Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
GemOx Sensitive: A2 - Guideline
|
GemOx Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
TI-CE Sensitive: A2 - Guideline
|
TI-CE Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
carboplatin + etoposide IV Sensitive: A2 - Guideline
|
carboplatin + etoposide IV Sensitive: A2 - Guideline
|
No biomarker
|
Testicular Cancer
|
No biomarker
|
Testicular Cancer
|
GemPOx Sensitive: A2 - Guideline
|
GemPOx Sensitive: A2 - Guideline
|